Cargando…
Sex dimorphism in response to targeted therapy and immunotherapy in non-small cell lung cancer patients: a narrative review
BACKGROUND AND OBJECTIVE: Multiple agents have been developed for treating non-small cell lung cancer (NSCLC). However, patients’ response to these therapies vary drastically, which indicates a need to tailor therapy. Sex is a readily usable clinical characteristic that has been shown to impact pati...
Autores principales: | Huang, Yingbo, Cho, Hyeong Joo, Stranger, Barbara E., Huang, R. Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186178/ https://www.ncbi.nlm.nih.gov/pubmed/35693273 http://dx.doi.org/10.21037/tlcr-21-1013 |
Ejemplares similares
-
Deciphering genetic causes for sex differences in human health through drug metabolism and transporter genes
por: Huang, Yingbo, et al.
Publicado: (2023) -
Targeted therapies and immunotherapy in non-small-cell lung cancer
por: Cortinovis, D, et al.
Publicado: (2016) -
Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer. A Narrative Review
por: Gatteschi, Lavinia, et al.
Publicado: (2021) -
Perioperative Targeted Therapy Or Immunotherapy In Non-Small-Cell Lung Cancer
por: Sa, Huanlan, et al.
Publicado: (2019) -
Immunotherapy as a targeted therapy in non-small cell lung cancer
por: Rocco, Danilo, et al.
Publicado: (2019)